RADHAKISHAN PHARMACEUTICALS
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG
ERLONAT ERLOTINIB TABLETS 150 MG

ERLONAT ERLOTINIB TABLETS 150 MG

ERLONAT ERLOTINIB TABLETS 150 MG Specification

  • Pacakaging (Quantity Per Box)
  • 30 Tablets
  • Indication
  • EGFR Mutation-Positive Non-Small Cell Lung Cancer, Pancreatic Cancer
  • Salt Composition
  • Erlotinib 150 mg
  • Origin of Medicine
  • India
  • Dosage Form
  • Tablet
  • Drug Type
  • Targeted Therapy
  • Ingredients
  • Erlotinib Hydrochloride
  • Physical Form
  • Tablets
  • Function
  • Anti-Cancer
  • Recommended For
  • Non-Small Cell Lung Cancer, Pancreatic Cancer
  • Dosage
  • As directed by physician
  • Dosage Guidelines
  • Take orally, do not crush or chew, preferably on an empty stomach
  • Suitable For
  • Adults
  • Quantity
  • 30 Tablets per Box
  • Storage Instructions
  • Store below 30C, protect from light and moisture
  • Contraindications
  • Hypersensitivity to erlotinib or any ingredients in the formulation
  • Route of Administration
  • Oral
  • MRP
  • As per label
  • Appearance
  • White to off-white round tablets, film-coated
  • Availability
  • Hospital supply, pharmacies, online order
  • Prescription/Non Prescription
  • Prescription
  • Side Effects
  • Rash, diarrhea, loss of appetite, fatigue, shortness of breath
  • Batch Number
  • As per packaging
  • Brand Name
  • Erlonat
  • Therapeutic Class
  • Antineoplastic agents
  • ATC Code
  • L01XE03
  • Expiry Period
  • 24 months from manufacture date
  • International Shipping
  • Available
 

ERLONAT ERLOTINIB TABLETS 150 MG Trade Information

  • Packaging Details
  • PACK OF 30 TABLETS
 

About ERLONAT ERLOTINIB TABLETS 150 MG

Product Name - Erlonat 150 Mg Tablets

Specification

  • Content - Erlotinib Hydrochloride
  • Form - Tablets
  • Strength - 25 Mg, 100Mg, 150 Mg
  • Packing - Pack Of 30 Tablets
  • Manufactured By : Natco

Note :- Erlonat Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............



Targeted Therapy for Cancer

Erlonat Erlotinib 150 mg functions as a highly specific targeted therapy designed to block the growth of cancer cells in adults with certain types of lung and pancreatic cancers. Its primary benefit lies in treating EGFR mutation-positive non-small cell lung cancer and advanced pancreatic cancer, offering a tailored approach that aims to minimize damage to healthy cells. This therapy is a vital part of modern oncological care and supports improved outcomes for eligible patients.


Proper Usage and Administration

Erlonat tablets are intended for oral administration as directed by a physician. For optimal absorption and efficacy, the medication should be taken on an empty stomach, at least one hour before or two hours after eating. The tablets must not be crushed or chewed. Dosage varies based on individual medical conditions and response to therapy. Patients are strongly advised to follow their healthcare providers instructions and never adjust their dose independently.


Storage and Handling Guidelines

For maximum efficacy, Erlonat 150 mg tablets must be stored below 30C and protected from light and moisture. Each box holds 30 tablets, with packaging details and batch number clearly marked. Always keep the medication in its original packaging to preserve its integrity, and ensure it is out of reach of children. Initiate each new supply only after checking the expiry date and batch details on the label, given the 24-month shelf life from manufacturing.

FAQs of ERLONAT ERLOTINIB TABLETS 150 MG:


Q: How should Erlonat Erlotinib 150 mg tablets be taken for best results?

A: Erlonat tablets should be swallowed whole with water, taken on an empty stomachat least one hour before or two hours after eating. Follow your doctors specific dosage instructions and do not crush or chew the tablets.

Q: What types of cancer is Erlonat indicated for?

A: Erlonat is indicated for the treatment of EGFR mutation-positive non-small cell lung cancer and advanced pancreatic cancer in adult patients, as determined by your physician.

Q: When should I avoid taking Erlonat Erlotinib tablets?

A: You should avoid taking Erlonat if you have a known hypersensitivity to erlotinib or any ingredients in the formulation. Inform your doctor of any allergies or prior adverse reactions before starting therapy.

Q: Where can I obtain Erlonat Erlotinib 150 mg tablets?

A: Erlonat is available via hospital pharmacies, authorized retail pharmacies, and select online platforms, with the option for international shipping in accordance with prescription requirements.

Q: What side effects should I watch for while using Erlonat?

A: Common side effects include rash, diarrhea, loss of appetite, fatigue, and shortness of breath. Contact your healthcare provider if these symptoms are severe or persistent, or if you experience any unusual reactions.

Q: What are the storage requirements for Erlonat tablets?

A: Store Erlonat below 30C, away from light and moisture, and in the original packaging. Check the expiry date and batch number before use and keep the medication out of reach of children.

Q: How does Erlonat benefit patients with cancer?

A: Erlonat provides a targeted approach to inhibiting cancer cell growth in specific types of lung and pancreatic cancer, contributing to better disease management with tailored therapy based on genetic mutations.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

TENVIR EM TABLETS

TENVIR EM TABLETS

Dosage Guidelines : Once daily with or without food, as directed by the healthcare provider

Origin of Medicine : India

Physical Form : Tablets

Dosage : As prescribed by the physician

Storage Instructions : Store below 30C, protect from light and moisture

VINELBINE VINORELBINE INJECTION

VINELBINE VINORELBINE INJECTION

Dosage Guidelines : Intravenous use only, dosage as per prescription

Origin of Medicine : Allopathic

Physical Form : Liquid

Dosage : As directed by physician

Storage Instructions : Store in a refrigerator (2C 8C), do not freeze, protect from light

CRESP DARBEPOETIN   INJECTION

CRESP DARBEPOETIN INJECTION

Dosage Guidelines : Administer as a subcutaneous or intravenous injection as directed by physician

Origin of Medicine : Biotechnologyderived

Physical Form : Other, Injection

Dosage : As prescribed by the physician, typically based on patient weight and hemoglobin levels

Storage Instructions : Store in a refrigerator (2C8C). Do not freeze. Protect from light.

LUPRODEX LEUPROLIDE ACETATE INJECTION

LUPRODEX LEUPROLIDE ACETATE INJECTION

Dosage Guidelines : To be administered by a healthcare professional as per dosage schedule

Origin of Medicine : Imported

Physical Form : Other, Injection

Dosage : As prescribed by the physician, commonly 3.75 mg or 11.25 mg per administration

Storage Instructions : Store in a refrigerator (2C 8C); Do not freeze



Back to top